Michaela Patz

709 total citations
12 papers, 441 citations indexed

About

Michaela Patz is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Michaela Patz has authored 12 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Michaela Patz's work include Chronic Lymphocytic Leukemia Research (10 papers), Phagocytosis and Immune Regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michaela Patz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Phagocytosis and Immune Regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michaela Patz collaborates with scholars based in Germany, United States and Switzerland. Michaela Patz's co-authors include Clemens‐Martin Wendtner, Michael Hallek, Christian P. Pallasch, Günter Krause, Lukas P. Frenzel, Julia Claasen, Christian Klein, Pablo Umaña, Alexandra Schulz and Christine Mayr and has published in prestigious journals such as Journal of Biological Chemistry, Blood and British Journal of Haematology.

In The Last Decade

Michaela Patz

12 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Patz Germany 8 217 209 145 100 100 12 441
María Hernández‐Sánchez Spain 14 232 1.1× 196 0.9× 149 1.0× 138 1.4× 60 0.6× 42 451
Michela Frenquelli Italy 13 300 1.4× 367 1.8× 173 1.2× 260 2.6× 121 1.2× 19 720
Anna Ferrer Spain 9 190 0.9× 243 1.2× 193 1.3× 104 1.0× 180 1.8× 11 499
Scott A. Ezell United States 10 89 0.4× 339 1.6× 121 0.8× 76 0.8× 61 0.6× 11 552
Cristina Largo Spain 9 113 0.5× 268 1.3× 133 0.9× 66 0.7× 99 1.0× 12 481
Viktor Ljungström Sweden 11 127 0.6× 139 0.7× 110 0.8× 54 0.5× 78 0.8× 23 323
Kamlai Saiya-Cork United States 11 201 0.9× 191 0.9× 222 1.5× 131 1.3× 64 0.6× 15 480
Simona Tavolaro Italy 16 384 1.8× 401 1.9× 282 1.9× 221 2.2× 156 1.6× 31 820
Alberto J. Arribas Switzerland 11 136 0.6× 185 0.9× 220 1.5× 91 0.9× 75 0.8× 50 430
Chingiz Underbayev United States 10 394 1.8× 228 1.1× 335 2.3× 230 2.3× 166 1.7× 18 671

Countries citing papers authored by Michaela Patz

Since Specialization
Citations

This map shows the geographic impact of Michaela Patz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Patz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Patz more than expected).

Fields of papers citing papers by Michaela Patz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Patz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Patz. The network helps show where Michaela Patz may publish in the future.

Co-authorship network of co-authors of Michaela Patz

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Patz. A scholar is included among the top collaborators of Michaela Patz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Patz. Michaela Patz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Patz, Michaela, Iris Gehrke, Julia Claasen, et al.. (2012). Comparison of the Effects of Two Kinase Inhibitors, Sorafenib and Dasatinib, on Chronic Lymphocytic Leukemia Cells. Oncology Research and Treatment. 35(7-8). 420–426. 9 indexed citations
3.
Schwamb, Janine, Michaël Baumann, Michaela Patz, et al.. (2012). B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood. 120(19). 3978–3985. 43 indexed citations
4.
Frenzel, Lukas P., Julia Claasen, Sebastian Theurich, et al.. (2012). Impact of Hypoxia As Novel Microenvironmental Factor On Drug Susceptibility of Primary CLL Cells. Blood. 120(21). 3918–3918. 2 indexed citations
5.
Asim, Mohammad, Bilal Bin Hafeez, Imtiaz A. Siddiqui, et al.. (2011). Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase. Journal of Biological Chemistry. 286(43). 37108–37117. 35 indexed citations
6.
Patz, Michaela, Christian P. Pallasch, & Clemens‐Martin Wendtner. (2010). Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. Leukemia & lymphoma. 51(8). 1379–1381. 14 indexed citations
7.
Frenzel, Lukas P., Michaela Patz, Christian P. Pallasch, et al.. (2010). Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis. British Journal of Haematology. 152(2). 191–200. 25 indexed citations
8.
Patz, Michaela, Lukas P. Frenzel, Clemens‐Martin Wendtner, et al.. (2010). Comparison of the in vitro effects of the anti‐CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells. British Journal of Haematology. 152(3). 295–306. 101 indexed citations
9.
Frenzel, Lukas P., Michaela Patz, Christian P. Pallasch, et al.. (2010). Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis. Blood. 116(21). 1375–1375. 2 indexed citations
10.
Pallasch, Christian P., Michaela Patz, Yoon Jung Park, et al.. (2009). miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114(15). 3255–3264. 118 indexed citations
11.
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Hernández‐Sánchez Breakdown of academic impact, for papers by Michela Frenquelli Breakdown of academic impact, for papers by Anna Ferrer Breakdown of academic impact, for papers by Scott A. Ezell Breakdown of academic impact, for papers by Cristina Largo Breakdown of academic impact, for papers by Viktor Ljungström Breakdown of academic impact, for papers by Kamlai Saiya-Cork Breakdown of academic impact, for papers by Simona Tavolaro Breakdown of academic impact, for papers by Alberto J. Arribas Breakdown of academic impact, for papers by Chingiz Underbayev
Rankless by CCL
2026